Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients

Phase 4 Unknown 200 enrolled Asian-Pacific Alliance of Liver Disease, Beijing Beijing Ditan Hospital · collab Hebei Medical University Pharmaceutical Factory · collab National Health and Family Planning Commission, P.R.China · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study evaluates generic emtricitabine(FTC) in Chinese naive children chronic hepatitis B patients. Single group of child patients were enrolled, which include HBeAg positive and negative Chronic hepatitis B(CHB)group.

Timeline

Start: 2015-01
Primary completion: 2015-07
Completion: 2016-07

Publications

Background Gish RG, Leung NW, Wright TL, Trinh H, Lang W, Kessler HA, Fang L, Wang LH, Delehanty J, Rigney A, Mondou E, Snow A, Rousseau F. Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infection. Antimicrob Agents Chemother. 2002 Jun;46(6):1734-40. doi: 10.1128/AAC.46.6.1734-1740.2002.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	emtricitabine	Other / unclassified	200 mg	Oral

Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients

Summary

Timeline

Publications

Drugs

Indications